These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 12714819

  • 1. Intravenous itraconazole followed by oral itraconazole for the treatment of amphotericin-B-refractory invasive pulmonary aspergillosis.
    Caillot D.
    Acta Haematol; 2003; 109(3):111-8. PubMed ID: 12714819
    [Abstract] [Full Text] [Related]

  • 2. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.
    Caillot D, Bassaris H, McGeer A, Arthur C, Prentice HG, Seifert W, De Beule K.
    Clin Infect Dis; 2001 Oct 15; 33(8):e83-90. PubMed ID: 11550120
    [Abstract] [Full Text] [Related]

  • 3. Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.
    Harousseau JL, Dekker AW, Stamatoullas-Bastard A, Fassas A, Linkesch W, Gouveia J, De Bock R, Rovira M, Seifert WF, Joosen H, Peeters M, De Beule K.
    Antimicrob Agents Chemother; 2000 Jul 15; 44(7):1887-93. PubMed ID: 10858349
    [Abstract] [Full Text] [Related]

  • 4. Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy. A randomized, controlled trial.
    Boogaerts M, Winston DJ, Bow EJ, Garber G, Reboli AC, Schwarer AP, Novitzky N, Boehme A, Chwetzoff E, De Beule K, Itraconazole Neutropenia Study Group.
    Ann Intern Med; 2001 Sep 18; 135(6):412-22. PubMed ID: 11560454
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of intravenous itraconazole against invasive pulmonary aspergillosis in neutropenic mice.
    Tansho S, Abe S, Ishibashi H, Torii S, Otani H, Ono Y, Yamaguchi H.
    J Infect Chemother; 2006 Dec 18; 12(6):355-62. PubMed ID: 17235640
    [Abstract] [Full Text] [Related]

  • 6. [Combination therapy of micafungin and itraconazole for a case of pulmonary aspergillosis].
    Maruyama T, Takagi T, Yuda H.
    Nihon Kokyuki Gakkai Zasshi; 2005 Feb 18; 43(2):94-8. PubMed ID: 15770940
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy.
    Boogaerts MA, Maertens J, Van Der Geest R, Bosly A, Michaux JM, Van Hoof A, Cleeren M, Wostenborghs R, De Beule K.
    Antimicrob Agents Chemother; 2001 Mar 18; 45(3):981-5. PubMed ID: 11181397
    [Abstract] [Full Text] [Related]

  • 8. Intravenous and oral itraconazole versus intravenous and oral fluconazole for long-term antifungal prophylaxis in allogeneic hematopoietic stem-cell transplant recipients. A multicenter, randomized trial.
    Winston DJ, Maziarz RT, Chandrasekar PH, Lazarus HM, Goldman M, Blumer JL, Leitz GJ, Territo MC.
    Ann Intern Med; 2003 May 06; 138(9):705-13. PubMed ID: 12729424
    [Abstract] [Full Text] [Related]

  • 9. Itraconazole prophylaxis for invasive gingival aspergillosis in neutropenic patients with acute leukemia.
    Myoken Y, Sugata T, Kyo T, Fujihara M, Mikami Y.
    J Periodontol; 2002 Jan 06; 73(1):33-8. PubMed ID: 11846198
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A pharmacokinetic study of intravenous itraconazole followed by oral administration of itraconazole capsules in patients with advanced human immunodeficiency virus infection.
    Zhou H, Goldman M, Wu J, Woestenborghs R, Hassell AE, Lee P, Baruch A, Pesco-Koplowitz L, Borum J, Wheat LJ.
    J Clin Pharmacol; 1998 Jul 06; 38(7):593-602. PubMed ID: 9702843
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.
    Patterson TF, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, Rinaldi MG, Stevens DA, Graybill JR.
    Medicine (Baltimore); 2000 Jul 06; 79(4):250-60. PubMed ID: 10941354
    [Abstract] [Full Text] [Related]

  • 15. European experience with oral solution and intravenous itraconazole.
    Potter M.
    Oncology (Williston Park); 2001 Nov 06; 15(11 Suppl 9):27-32. PubMed ID: 11757848
    [Abstract] [Full Text] [Related]

  • 16. [Chronic necrotizing pulmonary aspergillosis treated with itraconazole and inhaled amphotericin B].
    Sato A, Nakatani K, Matsushita Y, Matsuo H, Yamadori H, Kurasawa T, Ikeda Y.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Oct 06; 33(10):1141-5. PubMed ID: 8544389
    [Abstract] [Full Text] [Related]

  • 17. [An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis].
    Tomioka H, Kaneda T, Kida Y, Kaneko M, Fujii H, Hayashi M, Tomii K, Tada K, Suzuki Y, Karino T.
    Kansenshogaku Zasshi; 2011 Nov 06; 85(6):644-51. PubMed ID: 22250455
    [Abstract] [Full Text] [Related]

  • 18. [Case of chronic necrotizing pulmonary aspergillosis successfully treated with a combination of liposomal amphotericin B and itraconazole].
    Kiyokawa H, Nakashima R, Takafuji S, Suzuki Y, Ito A.
    Nihon Kokyuki Gakkai Zasshi; 2008 Jun 06; 46(6):448-54. PubMed ID: 18592989
    [Abstract] [Full Text] [Related]

  • 19. Effect of direct infusion of antifungal agent on invasive pulmonary aspergillosis in a patient with acute leukemia.
    Nakase K, Yazaki A, Tamaki S, Tanigawa M, Tsuji K, Miyanishi E, Shiku H.
    J Infect Chemother; 2002 Mar 06; 8(1):106-8. PubMed ID: 11957130
    [Abstract] [Full Text] [Related]

  • 20. Itraconazole for experimental pulmonary aspergillosis: comparison with amphotericin B, interaction with cyclosporin A, and correlation between therapeutic response and itraconazole concentrations in plasma.
    Berenguer J, Ali NM, Allende MC, Lee J, Garrett K, Battaglia S, Piscitelli SC, Rinaldi MG, Pizzo PA, Walsh TJ.
    Antimicrob Agents Chemother; 1994 Jun 06; 38(6):1303-8. PubMed ID: 8092829
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.